This task order establishes services for storage and stability of AS03 adjuvant manufactured to support the covid-19 federal response in bulk lots and final containers for the life of the material.…
Active Awarded Last action
- Contract number
- 75A50124F61015
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $11,538,800
Award facts
- Contract value 100% obligated
- $11,538,800.00 Current and potential, with all options
- Completion date 34% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27701, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $11,538,800 |
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a delivery order to Glaxosmithkline, LLC on June 17, 2024, with a ceiling value of $11.5388 million, for services for storage and stability of AS03 adjuvant manufactured to support the COVID-19 federal response. The scope covers bulk lots and final containers for the life of the material, and all option periods are exercised under the order. Performance is in Durham, NC, with an ultimate completion date of May 21, 2031. The order is firm fixed price and was issued without a set-aside. The prime is a foreign-owned, for-profit pharmaceutical manufacturer with no SBA set-aside designations.
Description
This task order establishes services for storage and stability of AS03 adjuvant manufactured to support the covid-19 federal response in bulk lots and final containers for the life of the material. All option periods are hereby exercised under this
Quick answers
Who was awarded contract 75A50124F61015?
75A50124F61015 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on June 17, 2024.
How much is contract 75A50124F61015 worth?
The government has obligated $11,538,800 on 75A50124F61015.
Is contract 75A50124F61015 an order under another contract?
Yes. 75A50124F61015 is a delivery order under 75A50122D00002, an indefinite delivery contract.
Was contract 75A50124F61015 competed?
The extent of competition for 75A50124F61015 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award